四种心血管风险算法在系统校准后趋于一致:86项前瞻性研究的个体参与者荟萃分析
原始算法判别力相似但校准差异大(FRS、SCORE、PCE分别平均高估10%、52%、41%,RRS低估10%);系统校准后各算法性能几乎一致,并将高风险比例从29-39%降至22-24%。
要点
- 原始FRS、SCORE、PCE分别高估CVD风险10%、52%、41%,RRS低估10%。
- 校准后四种算法判别力相似,高风险比例统一降至22-24%。
- 原始算法需治疗44-51人以预防1例CVD事件,校准后降至37-39人。
核心结论
- 校准前四种常用CVD风险算法临床性能差异显著,简单校准后性能几乎一致并改善了对预防措施的目标定位。
主要发现
- 四种算法判别力相似;校准前FRS、SCORE、PCE分别平均高估CVD风险10%、52%、41%,RRS低估10%。
- 原始算法将29-39%的≥40岁个体归为高风险,校准后降至22-24%。
- 预防1例CVD事件需启动他汀治疗的人数:原始算法44-51人,校准后37-39人。
关键数值与推荐
- SCORE原始版本平均高估10年CVD风险52%,PCE高估41%,FRS高估10%,RRS低估10%。
临床怎么用
- 使用原始算法评估CVD风险时需注意其高估或低估倾向,校准后可更准确识别高风险人群并优化他汀治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: There is debate about the optimum algorithm for cardiovascular disease (CVD) risk estimation. We conducted head-to-head comparisons of four algorithms recommended by primary prevention guidelines, before and after 'recalibration', a method that adapts risk algorithms to take account of differences in the risk characteristics of the populations being studied. METHODS AND RESULTS: Using individual-participant data on 360 737 participants without CVD at baseline in 86 prospective studies from 22 countries, we compared the Framingham risk score (FRS), Systematic COronary Risk Evaluation (SCORE), pooled cohort equations (PCE), and Reynolds risk score (RRS). We calculated measures of risk discrimination and calibration, and modelled clinical implications of initiating statin therapy in people judged to be at 'high' 10 year CVD risk. Original risk algorithms were recalibrated using the risk factor profile and CVD incidence of target populations. The four algorithms had similar risk discrimination. Before recalibration, FRS, SCORE, and PCE over-predicted CVD risk on average by 10%, 52%, and 41%, respectively, whereas RRS under-predicted by 10%. Original versions of algorithms classified 29-39% of individuals aged ≥40 years as high risk. By contrast, recalibration reduced this proportion to 22-24% for every algorithm. We estimated that to prevent one CVD event, it would be necessary to initiate statin therapy in 44-51 such individuals using original algorithms, in contrast to 37-39 individuals with recalibrated algorithms. CONCLUSION: Before recalibration, the clinical performance of four widely used CVD risk algorithms varied substantially. By contrast, simple recalibration nearly equalized their performance and improved modelled targeting of preventive action to clinical need.
引用
- Pennells L, Kaptoge S, Wood A, et al. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. Eur Heart J. 2019. PMID: 30476079. doi:10.1093/eurheartj/ehy653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。